Background-In the absence of overt structural heart disease, most left ventricular outflow tract ventricular tachycardias (VTs) have a focal origin and are benign. We hypothesized that multiple morphologies (MMs) of inducible left ventricular outflow tract VT may indicate a scar-related VT that can mimic idiopathic VT. Methods and Results-Of 54 consecutive patients referred for ablation of sustained outflow tract VT without overt structural heart disease, 24 had left ventricular outflow tract VT, 10 had MM VT, and 14 had a single VT (SM). The MM group were older (70.3±4.3 versus 53.9±15.9 years; P=0.004), had more hypertension (100% versus 29%; P=0.0006), and had longer PR intervals and QRS durations compared with the SM group. In contrast to the SM group, the MM group VTs had features consistent with reentry, including induction by programmed stimulation without isoproterenol, entrainment in some, and abnormal electrograms in the periaortic area. Periaortic region voltages suggested scar in the MM group, but not in the SM group. MRI in 2 MM patients was consistent with scar, but not in 10 SM patients. Longer radiofrequency applications were required in the MM group than in the SM group. At a median follow-up of 9.7 (3.0-32.0) months, recurrences tended to be more frequent in the MM group than in the SM group (70% versus 22%; P=0.07). Conclusions-VTs from small regions of periaortic scar can mimic idiopathic VT but are suggested by multiple VT morphologies and are more difficult to ablate. Whether these patients are at greater risk, as feared for other scar-related VTs, warrants further study. (Circ Arrhythm Electrophysiol. 2014;7:99-106.)
V entricular tachycardia (VT) originating from the periaortic region can occur in the absence of structural heart disease. 1, 2 These VTs are generally categorized as idiopathic and often have features consistent with triggered activity due to delayed afterdepolarizations. 3, 4 A single morphology of VT originating from a focal site is typical, although exceptions having multiple morphologies (MMs) of VTs have been reported. 5 Areas of ventricular scar can occur along the valve annuli in cardiomyopathies and give rise to VT that often has characteristics consistent with reentry. We have observed what appear to be scar-related VTs from the periaortic area in patients with no other evidence of structural heart disease, but these have not been well described. Some patients have MMs of VT that is more consistent with scarrelated VT than idiopathic focal VT. The aim of this study was to characterize VTs and VT substrate that gives rise to periaortic VT, as well as specifically to assess the presence of electrogram evidence of scar in the region and the relation between VT characteristics, including MMs of VT, and scar.
Methods

Patient Characteristics
From a consecutive series of 54 patients (32 men; aged 54.2±14.0 years) who underwent ablation at our institution for sustained monomorphic VT (SMVT) originating from outflow tract (OT) area in the absence of structural heart disease, from January 2004 to April 2013, 24 patients who had SMVT originating from the periaortic region were included. Patients with a clinical history of only nonsustained (NS) arrhythmias were excluded. All patients underwent an assessment for the presence of overt structural heart disease with physical examination, 12-lead electrocardiography, chest x-ray, transthoracic echocardiography, exercise or pharmacological stress testing, or coronary angiography. MRI was often limited by previous implantable cardioverter defibrillator placement and was performed in only 12 patients. Patients with structural heart disease defined as a history of coronary artery disease, myocarditis, infiltrative February 2014 heart disease, valvular heart disease, hypertensive heart disease with depressed ventricular function (left ventricular ejection fraction [LVEF] <45%), congenital heart disease, dilated cardiomyopathy, or with LVEF <45% on any previous imaging study were excluded. All antiarrhythmic drugs except amiodarone were discontinued for ≥5 half-lives before the procedure. A reference group for periaortic bipolar voltage was obtained from 9 consecutive patients with no structural heart disease who had idiopathic premature ventricular contractions (PVCs; without VT) originating from the periaortic area who were studied between April 2012 and April 2013 (4 men; aged 55.2±12.2 years; LVEF, 57.3±7.4%).
Each patient gave written informed consent. Studies and data collection were performed according to protocols approved by the Human Research Committee of Brigham and Women's Hospital.
Electrophysiological Study
After local anesthesia, femoral venous or arterial access was obtained and multipolar electrode catheters were positioned in the right ventricular (RV) apex and the His bundle region. Programmed ventricular stimulation for the initiation of SMVT was performed with ≈3 extrastimuli scanned to refractoriness or a minimum coupling interval of 180 ms, applied after a basic drive of 600 ms and then 400 ms from 2 RV sites and burst pacing. If SMVT was not inducible, programmed stimulation was repeated during intravenous infusion of isoproterenol or epinephrine. The end point of ventricular stimulation was the induction of SMVT lasting >30 seconds or requiring termination because of hemodynamic intolerance or a shortest interstimulus interval of 180 to 200 ms. At the end of the procedure, the same stimulation protocol was repeated. Acute complete success was defined as the absence of any inducible SMVT.
Electroanatomical Mapping and Quantitative Assessment of Low-Voltage Area
Electroanatomical mapping was performed (CARTO 3 or XP; Biosense Webster Inc, Diamond Bar, CA) using a 3.5-mm tip open-irrigated catheter (NaviStar ThermoCool; Biosense Webster) or with a 4-mm tip nonirrigated catheter (NaviStar; Biosense Webster). In 10 patients, LVOT and aortic root was defined with intracardiac ultrasound imaging (64-element, 5.5-10.0 MHz; SoundStar; Biosense Webster). In the electroanatomic mapping system, bipolar electrograms were high pass-filtered at 20 to 30 Hz and low pass-filtered at 400 Hz. Bipolar electrograms were also band pass-filtered from 30 to 500 Hz and digitally recorded along with a 12-lead surface ECG using the Cardiolab EP system (General Electric Healthcare, Buckinghamshire, United Kingdom).
Voltage maps were created during sinus rhythm. Peak-to-peak bipolar electrogram amplitude <0.5 mV was defined as dense scar, and voltage ≥0.5 and <1.5 mV as scar border zone. 6 Low-voltage areas >2 cm 2 were measured using the standard surface area measurement tool on the CARTO system (version 9.0.34 in CARTO XP or 2.3 in CARTO 3).
Mapping Protocol and Ablation
Mapping of the RV endocardium and proximal pulmonary artery was performed in all patients, followed by mapping of the great cardiac vein, then the LV endocardium, and aortic root. Epicardial mapping was performed if endocardial mapping failed to identify the focus, either at the same or a subsequent session. Percutaneous subxiphoid epicardial access was obtained as previously described. 7 All inducible SMVTs were targeted for ablation. If SMVT was not reliably inducible, NSVT or PVCs felt likely to be originating from the same site were targeted. Pace mapping was also used. If VT was hemodynamically tolerated and reproducibly induced, mapping and ablation were performed during VT. Sites were targeted for ablation if pacing entrained the SMVT with concealed fusion and a postpacing interval <30 ms of the VT cycle length 8, 9 or an isolated mid-diastolic potential or presystolic potential was present. If focal origin VT was suspected, the site of earliest presystolic electric activity was targeted for ablation. If VTs were unmappable because of hemodynamic intolerance or poor reproducibility, ablation was guided by pace mapping and limited VT electrogram assessment. If a bipolar low-voltage area was present, substrate modification of the area was performed during sinus rhythm.
Ablation targeted presumptive channels and exits, as identified from a paced QRS morphology similar to the VT QRS morphology with stimulus-QRS interval >40 ms, abnormal fractionated potentials, double potentials, or late potentials during sinus or paced rhythm at sites where pacing captured. Pace mapping and entrainment mapping used unipolar stimuli with strength of 10 mA and pulse width of 2 ms. 10 Radiofrequency (RF) energy was delivered at a power of 25 to 50 W targeting an impedance drop of 10 Ω. At target areas below the aortic valve (AV), applications were usually repeated until unipolar pacing at 10 mA at 2 ms stimulus strength failed to capture. 11 At target areas above the AV, power exceeding 35 W was avoided.
Data Collection and Follow-Up
Data were collected from a centralized system containing records of all patients treated and followed at Brigham and Women's Hospital and all associated Partners HealthCare sites. Referring cardiologists and primary care physicians were contacted for clinical follow-up of their patients if necessary.
Statistical Analysis
Continuous variables were expressed as mean±SD, or median and interquartile ranges (IQRs) are shown in parentheses, as appropriate. Student t test or Mann-Whitney U-test was used to compare continuous variables, depending on whether the values were normally distributed, and the Fisher exact test was used to compare dichotomous variables. For age-adjusted comparisons, we used the analysis of covariance for continuous variables and the likelihood ratio test with logistic regression for dichotomous variables. P<0.05 was considered statistically significant. All statistical analyses were performed with JMP 9 software (SAS Institute, Cary, NC).
Results
Baseline Characteristics
Periaortic SMVT was identified in 24 patients. In 10 patients, MMs of SMVTs were induced (MM group), whereas only a single SMVT, NSVT, or PVC morphology was induced in 14 patients (single morphology [SM] group). The characteristics of patients in the SM and MM groups are shown in Table 1 . Older age (70.3±4.3 versus 53.9±15.9 years; P=0.004) and hypertension (100% versus 29%; P=0.0006) were more frequent in the MM group. However, there was no significant difference in sex, body mass index, prevalence of hyperlipidemia, or history of previous ablation between the 2 groups. No patient had a history of cardiac arrest in either group. A history of syncope was present in 2 (20%) MM and 5 (36%) SM patients (P=0.65). Implantable cardioverter defibrillators had been previously placed in 7 (70%) of the MM group, but only 1 patient (7%) in the SM group.
The MM group had more evidence of mild cardiac impairment often associated with age and hypertension ( Table 1) . The sinus rhythm QRS duration was longer (115.8±19.3 versus 94.1±12.6 ms; P=0.004) and left axis deviation was more frequent (−23.8±27.2° versus 30.5±29.7 °; P=0.0002) in the MM group compared with the SM group; the PR interval was longer but not significantly so after age adjustment. On echocardiography, the E/A ratio was lower and the E/e′ ratio was greater in the MM group, consistent with impaired diastolic function, 12 as compared with the SM group. However, there were no significant differences between the 2 groups with respect to heart rate, LVEF, interventricular septum thickness, and aortic root diameter. After age adjustment, precordial T-wave inversion in ≥2 leads was more frequent in the MM group compared with the SM group. MRI was obtained in 10 patients in the SM group and only 2 in the MM group, showing an area of late gadolinium enhancement in both MM patients compared with none in the SM group, but with these small numbers, these differences are not significant.
Electrophysiological Characteristics
There were striking differences in VT findings between the MM and SM groups. A mean of 3 (IQR, 2-4) different SMVTs was induced in the MM group. SMVT was more likely to be induced during the procedure in the MM group (100%) compared with the SM group (36%; P=0.002). Infusion of isoproterenol or epinephrine to induce SMVT was required in only 10% of the MM group, but was needed in 71% of the SM group (P=0.005). SMVTs in the SM group were more likely to occur spontaneously (60% versus 0%; P=0.02) and less likely to be induced by extrastimli (0% versus 70%; P=0.03) as compared with the MM group (although these differences are not significant after age adjustment).
In the SM group, induced VT was thought to be consistent with clinical VT. This was less certain for the MM group. In the MM group, SMVTs exhibited either right or left bundle branch block morphology with relatively early precordial transition and inferior axis ( Figure 1A ; Figure I in the Data Supplement). VTs did not differ between the 2 groups with respect to QRS duration, bundle branch block configuration in V1, axis deviation, and precordial transition of VT. The MM group VTs tended to have a shorter VT cycle length compared with the SM group (331.0±66.4 versus 417.2±98.4 ms; P=0.07). Atrial-His bundle interval, His bundle-ventricular interval, and presence of ventriculo-atrial conduction were similar between the 2 groups. His bundle-ventricular interval was prolonged >55 ms in 5 MM and 4 SM patients.
Detailed VT characteristics in the MM group are shown in the Data Supplement. Seven VTs in 3 patients exhibited spontaneous transition to a different VT morphology. Pacing Values are the mean±SD, median (25th-75th interquartile range), or n (%). ICD indicates implantable cardioverter defibrillator; LGE, late gadolinium enhancement; MM, multiple morphologies; SM, single morphology; and SMVT, sustained monomorphic ventricular tachycardia. February 2014 for entrainment was attempted during 17 VTs in 9 patients in the MM group; constant fusion was observed in 15 VTs in 9 patients; and progressive fusion was also observed in 2 of these patients. In 2 patients, entrainment with concealed fusion and a postpacing interval <30 ms of the VT cycle length occurred. In 3 patients, attempted entrainment pacing during SMVT induced a different SMVT. Mid-diastolic potentials were observed in 3 patients. In the SM group, entrainment was attempted in 2 patients and failed to produce constant fusion in either.
Voltage Maps and Electrograms
Bipolar electrogram voltage for the SM and MM groups was compared with that from a reference group with idiopathic PVCs for maps in which the aortic annulus location was defined by intracardiac ultrasound in 8 patients in the MM group and 2 patients in SM group (Figure 2 ). Bipolar voltages at both 1.0 and 1.5 cm from the AV annulus were <1.5 mV in all patients in the MM group, but were >1.5 mV in all patients in the idiopathic PVC group and in both patients in the SM group. Periaortic region voltages at 1 and 1.5 cm from the aortic root were significantly lower in the MM patients compared with the idiopathic PVC patients (1.0 cm, 0.55±0.17 versus 2.46±0.85 mV; P<0.0001; 1.5 cm, 0.88±0.32 versus 3.26±1.19 mV; P<0.0001). In the MM group, the periaortic area of <1.5 mV was 18.5±8.9 cm 2 in size.
Some abnormal electrograms in the periaortic region with fractionation, late potentials, or double potentials were observed in all patients in the MM group ( Figure 1B ; Figure  II in 
Ablation
Ablation abolished all inducible VTs in 11 of 14 SM (79%) and 7 of 10 MM patients (70%; P=0.67). Of 5 SM patients in whom ablation was performed during VT, VT terminated in 4 patients. In the other 9 SM patients, PVCs (n=5) or NSVTs (n=4) were targeted as a surrogate marker of VT, and no arrhythmia was inducible after ablation in 7 patients. The ablation site that abolished the arrhythmia was in a coronary cusp in 5 of 11 patients and in the great cardiac vein in 1 patient (Table 3 ).
In the MM group, ablation was performed during VT and terminated VT in 5 patients (at the LVOT in 4, left coronary cusp in 1). However, all had other morphologies of VT inducible, and further ablation was performed during sinus rhythm or other induced VTs (Table 3 ). In 5 patients, ablation was performed only during sinus rhythm. Ablation at >1 region was performed in 6 patients. Ablation was performed below the AV in all, in the left coronary cusp in 2 patients with termination of a VT in 1, in the right coronary cusp during sinus rhythm in 1, and at the basal LV septum below the His bundle in 1. In 4 patients, ablation was also performed in the RVOT opposite the sites of LV ablation. No RF energy was delivered from within the pericardial space, although epicardial mapping was performed in 4 patients.
There was no difference in acute success between the 2 groups ( Table 2) Table 2 ).
Discussion
To our knowledge, this is the first study to define 2 groups of patients with periaortic sustained VTs in the setting of normal ventricular function. One group had focal VT that is consistent with idiopathic OT VT. The second group had evidence of reentry in scar in the periaortic region. Electrophysiological findings consistent with reentry in scar include: (1) SMVTs induced by ventricular stimulation without isoproterenol or epinephrine infusion; (2) >1 morphology of SMVT occurring either spontaneously or with repeated programmed stimulation, pacing during VT, or ablation; (3) ablation in 1 region abolishing >1 morphology of VT; (4) entrainment; (5) abnormal electrograms and voltage maps consistent with scar; and (6) pace maps with S-QRS delays typically >40 ms. The reliability of assessing scar from voltage maps in periannular locations is limited by the smaller amount of myocardium adjacent to the valve annulus as compared with the body of the ventricle. Hence, studies that defined 1.5 mV as a useful indicator of scar excluded the periannular region. 6 Similar concerns apply to the use of unipolar electrograms, which were not evaluated in this study. 13 However, lower voltages were present in the periaortic region in the MM group than in a group of patients with idiopathic PVCs. Bipolar electrogram amplitude 1 cm distant from the aortic annulus was <1 mV for all patients in the MM group, but exceeded 1 mV for the reference group and the SM group, suggesting that the criterion of <1 mV at 1 cm may be helpful in recognizing periaortic scar.
The cause of scar in the MM group is not clear. Age-related fibrosis or mild cardiomyopathy is possible. Older age and hypertension were more frequent in the MM group compared with the SM group, as were wider QRS duration and left axis deviation in sinus rhythm that might reflect mild impairment of the LV conduction system or cardiac remodeling that can be associated with aging, hypertension, or cardiomyopathies. [14] [15] [16] Echocardiographic evidence of impaired LV diastolic function is also consistent with these processes and often precedes the development of LV systolic dysfunction. [17] [18] [19] [20] VTs in the MM group have been more difficult to ablate, often require multiple RF applications, sometimes at sites both below and above the AV annulus, and recurrences are common. The periaortic region can be thick and intramural reentry circuits are possible, making ablation challenging. Furthermore, the access to the periaortic region is often limited by the overlying RVOT and pulmonary artery, and more leftward by epicardial fat and coronary vessels. 21, 22 Whether more aggressive ablation approaches could improve outcomes will need to be carefully evaluated in relation to the potential risk to adjacent structures, including the aortic and mitral valves, coronary arteries, and the AV conduction system. Furthermore, novel ablation strategies, including transcoronary ethanol ablation or needle ablation, likely warrant investigation in these patients. Whether these VTs are associated with a risk of sudden death, in contrast to focal idiopathic VTs that they can mimic, is not clear, but the poor hemodynamic tolerance for some of these VTs do raise this possibility. Several of our patients had implantable cardioverter defibrillators before referral for ablation.
MRI with late gadolinium enhancement can be useful to detect arrhythmogenic scar in structural heart diseases. 23, 24 Although MRI data were available in only 2 patients in the MM group, late gadolinium enhancement was observed in the periaortic region in both the patients. MRI with late gadolinium enhancement may be helpful in recognizing these patients.
Limitations
The present study is a retrospective descriptive case series, with a relatively small number of patients. The characterization of VTs is incomplete in several patients because of hemodynamic intolerance and poor reproducibility of sustained VT initiation. Electrophysiological maneuvers and entrainment were not consistently performed in all patients. The mechanism of apparent focal VTs in the SM group is not proven. Although the methods of initiation are consistent with triggered activity, other pharmacological maneuvers were not performed, and a small reentry circuit cannot be excluded. 3, 4 Multiple morphologies of VT due to a focal origin with multiple exits are also possible. 25 The periaortic region can be thick and intramural reentry is possible, such that the complete circuit was not defined. Our patients were referred for ablation, and selection biases could have precluded an estimate of the frequency of these scar-related VTs. MRI analysis was limited because several patients had implantable cardioverter defibrillators before referral.
The definition of distance from the aortic annulus was accomplished by electroanatomic mapping and intracardiac ultrasound, which have some degree of measurement error.
Conclusions
There are 2 distinct groups of SMVTs that originate from the periaortic area in people with normal ventricular function. The first group, focal idiopathic VTs, has been well documented previously. The second group comprises VTs that are due to reentry in a small region of periaortic scar, which often give rise to MMs of VT. We speculate that these are because of aging or an early presentation of a cardiomyopathic process. The recognition of this entity has clinical relevance because the VTs seem to be more difficult to ablate, often require multiple RF applications below and above the valve annulus, and may have a higher risk of recurrence.
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